Serag Eldin I Elbehairi
Overview
Explore the profile of Serag Eldin I Elbehairi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
315
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain Y, You B, Huang L, Liu X, Dormocara A, Shah K, et al.
Int J Pharm
. 2025 Feb;
673:125382.
PMID: 39988214
Skin cancer is one among the common types of cancers, affecting millions of individual globally. The conventional anticancer therapy such as chemotherapy results in worst systemic and local side effects...
2.
Mokhtar F, Ahmed M, Al Dhanhani A, Elbehairi S, Alfaifi M, Shati A, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861127
This review evaluates the cytotoxic potential of the genus, with a focus on , , and . These species, known for their diverse phytochemical compositions, exhibit notable cytotoxic effects that...
3.
Alqahtani N, Alfaifi M, Shati A A, Elbehairi S, Saleh A, Kotb E, et al.
RSC Adv
. 2024 Dec;
14(52):39027-39039.
PMID: 39659603
Two new thiadiazole imidazolium salicylidene Schiff bases (TISSBs) were successfully synthesized, and their structures were analyzed comprehensively using spectroscopic techniques. The results of the MTT assay showed that TISSB2 was...
4.
Alhamdi H, Mokhtar F, Ridouane F, Shati A, Elbehairi S, Fahmy L, et al.
Artif Cells Nanomed Biotechnol
. 2024 Oct;
52(1):529-550.
PMID: 39462870
, has been widely recognized for its medical applications. LC-ESI-TOF-MS identified 22 secondary metabolites including phenolics, flavonoids, and anthocyanidin glycosides among its total extract (LCTE). The study aimed to apply...
5.
Abd El-Fattah W, Alfaifi M, Alkabli J, Ramadan H, Shati A, Elbehairi S, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335087
In the original publication [...].
6.
Iqbal S, Begum F, Alfaifi M, Elbehairi S, Siddique A, Shaw P
Probiotics Antimicrob Proteins
. 2024 Sep;
PMID: 39316258
The current study was designed to explore the biosynthetic potential of sevadicin in Bacillus pumilus species and its interaction with bacterial drug target molecules. The non-ribosomal peptide (NRP) cluster in...
7.
Alhamdi H, Alfaifi M, Shati A, Elbehairi S, Er-Rajy M, Elshaarawy R, et al.
RSC Adv
. 2024 Sep;
14(41):29890.
PMID: 39301240
[This corrects the article DOI: 10.1039/D4RA04219K.].
8.
Rajkumar M, Presley S, Menaa F, Elbehairi S, Alfaifi M, Shati A, et al.
Bioprocess Biosyst Eng
. 2024 Sep;
47(12):2111-2129.
PMID: 39284929
The synthesis of magnesium hydroxide nanoparticles (Mg(OH) NPs) using plant extracts are known to be a practical, economical, and an environmentally friendly approach. In this work, Mg(OH) NPs were synthesized...
9.
Alhamdi H, Alfaifi M, Shati A, Elbehairi S, Er-Rajy M, Elshaarawy R, et al.
RSC Adv
. 2024 Sep;
14(39):28555-28568.
PMID: 39247509
Recently, molecular hybrids of two or more active pharmacophores have shown promise for designing and synthesizing anticancer drugs. Herein, a new multifunctional hybrid (PAHMQ), combining azobenzene and quinoline pharmacophores, and...
10.
Awaji A, Alhamdi H, Alshehri K, Alfaifi M, Shati A, Elbehairi S, et al.
J Inorg Biochem
. 2024 Sep;
262:112720.
PMID: 39243420
This study investigated the effectiveness and safety of a hybrid thiosemicarbazone ligand (HL) and its metal complexes (Mn-L, Fe-L, Ni-HL, and Zn-HL) against epidermoid carcinoma (A-431). The results indicated that...